
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Public Health
Sec. Health Economics
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1513709
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Field hospitals, following the Fangcang Shelter Hospital model, were critical during the global COVID-19 pandemic to alleviate the strain on overwhelmed healthcare systems. Despite their widespread adoption, concerns persist regarding their efficacy and costeffectiveness. This study aimed to assess the impact of the Pacaembu Field Hospital in São Paulo, Brazil during the COVID-19 pandemic, specifically focusing on lives saved and the associated public health costs. Methods: This retrospective cohort study was conducted April 6 to June 29. The 200-bed field hospital, a collaboration between Sociedade Beneficente Israelita Brasileira Albert Einstein and the São Paulo City Hall, São Paulo Municipal Health Departament, operated at Pacaembu Stadium and admitted. adult patients with mild to moderate COVID-19. Electronic health records provided comprehensive data on demographics, clinical outcomes, and resource utilization. The mortality rate among field hospital patients was compared to that of two groups: I-confirmed COVID-19 cases in São Paulo, and II-severe acute respiratory syndrome patients with COVID-19 in São Paulo. Results: A total of 152,928 COVID-19 cases were confirmed in São Paulo, with 20,603 patients hospitalized for ARDS and 1,499 patients admitted to the Pacaembu Field Hospital for mild to moderate disease. The median age of Pacaembu patients was 57 years (IQR 46-67), with 43.8% aged 60 or older. Lung disease was the most common comorbidity, affecting 31.0% of cases. The median length of stay was 4.2 days, and 14.2% of patients required intensive care, with 7.9% needing mechanical ventilation. . The hospital had a survival rate of 99.8%. The cost per year of life saved, adjusted for gender, was R$44,243.02 (US$8,208.35). In the most favorable scenario, approximately 200 lives were saved, with a cost of R$5,640.92 (US$1,046.55) per life saved for both genders. In the least favorable scenario, around 50 lives were saved, with a cost of R$36,863.48 (US$6,839.24) per life saved for both genders, all within cost-effectiveness thresholds. Conclusion: The Pacaembu Field Hospital played a crucial role in saving lives during the initial COVID-19 wave, highlighting the importance of ongoing evaluation and resource optimization in field hospital strategies for an effective pandemic response.
Keywords: Field hospital, COVID-19, cost-effectiveness analysis, health-adjusted life years, pandemic
Received: 18 Oct 2024; Accepted: 26 Mar 2025.
Copyright: © 2025 Bernardez-Pereira, Schettino, Marra, Parreira, Racy, Miranda, Codeço, Jaures, Pagliuso, Neto, Laselva, Klajner, Teich, Giliberti, Kobayashi, Edmond and Malheiro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Daniel Tavares Malheiro, Albert Einstein Israelite Hospital, São Paulo, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.